Aspire Biopharma Holdings Inc Asset Turnover Ratio (ASBP), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Aspire Biopharma Holdings Inc   (NASDAQ: ASBP)
 

Aspire Biopharma Holdings Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Aspire Biopharma Holdings Inc asset turnover ratio, the ability of Aspire Biopharma Holdings Inc 's assets to generate revenue in the second quarter 2026, increased sequentially to 0.02 in the second quarter (Jun 30 2026), a new company high.

Within sector 185 more businesses have achieved higher asset turnover ratio. While asset turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ASBP Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 1268.5 % 262.1 % -78.77 % -60.36 % -84.4 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.02 0.01 0 0 -
ASBP's Total Ranking # # # # #
Seq. Asset Change 90.25 % 442.4 % -45.4 % 142.88 % -49.66 %
Seq. Revenue Change 89.15 % 682.96 % 119.53 % - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 186
Healthcare Sector # 537
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0.02 0.02 0.02
(Jun 30 2026)  




ASBP Company Profile • Back to ASBP Efficiency Comparisons • Compare ASBP Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Mangoceuticals Inc   0.02 $ 0.315  Millions$ 15.311  Millions
Bioxcel Therapeutics Inc   0.02 $ 0.742  Millions$ 38.133  Millions
Hyperion Defi inc   0.02 $ 1.401  Millions$ 79.440  Millions
Aspire Biopharma Holdings Inc   0.02 $ 0.103  Millions$ 6.093  Millions
Alumis inc   0.01 $ 7.398  Millions$ 533.040  Millions
Vyne Therapeutics Inc   0.01 $ 0.430  Millions$ 31.089  Millions
Vivosim Labs Inc   0.01 $ 0.112  Millions$ 8.892  Millions
Envoy Medical Inc   0.01 $ 0.207  Millions$ 17.628  Millions
Bellevue Life Sciences Acquisition Corp  0.01 $ 1.809  Millions$ 171.835  Millions
Cardiff Oncology Inc   0.01 $ 0.508  Millions$ 53.041  Millions
Sharps Technology Inc   0.01 $ 2.468  Millions$ 263.597  Millions
Clene Inc   0.01 $ 0.197  Millions$ 21.287  Millions
Scienture Holdings Inc   0.01 $ 0.821  Millions$ 89.351  Millions
Lightwave Logic Inc 0.00 $ 0.250  Millions$ 79.491  Millions
Pavmed Inc 0.00 $ 0.126  Millions$ 40.629  Millions
Prokidney Corp 0.00 $ 0.818  Millions$ 307.246  Millions
IMPACT BIOMEDICAL INC. 0.00 $ 0.035  Millions$ 17.361  Millions
Cardio Diagnostics Holdings Inc 0.00 $ 0.014  Millions$ 8.510  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.